medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 4

<< Back Next >>

Ann Hepatol 2012; 11 (4)

Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage

Messeri S, Messerini L, Vizzutti F, Laffi G, Marra F
Full text How to cite this article

Language: Spanish
References: 11
Page: 554-558
PDF size: 149.87 Kb.


Key words:

Nonalcoholic fatty liver disease, Celiac disease, Hepatitis, Autoimmune hepatitis.

ABSTRACT

Aminotransferase elevation is a frequent cause of consultation for the Hepatologist, in both the outpatient and inpatient settings, but identifying the origin of these biochemical alterations may be challenging. Here we report a case where acute elevation of aminotransferases, associated with abdominal symptoms, was the cause of two hospitalizations in a short period of time. As the patient suffered from type 1 diabetes, celiac disease, and autoimmune thyroiditis, several potential causes of damage could be hypothesized, including celiac hepatitis, fatty liver, and autoimmune hepatitis. A liver biopsy performed in the occasion of the second hospitalization allowed to rule out autoimmune hepatitis and celiac hepatitis, showing mild signs of fatty infiltration. Staining with periodic acid-Schiff with or without diastase showed a marked accumulation of glycogen, indicating the presence of a glycogenic hepatopathy associated with poorly controlled type 1 diabetes. This condition may be a cause of liver damage in patients with type 1 and occasionally type 2 diabetes, but its occurrence is often overlooked. This case report illustrates the fact that glycogenic hepatopathy may relapse, and prompts the clinician to take into account this condition in the differential diagnosis of causes of liver injury.


REFERENCES

  1. Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001; 35: 531-7.

  2. Torbenson M, Chen YY, Brunt E, et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006; 30: 508-13.

  3. Munns CF, McCrossin RB, Thomsett MJ, et al. Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health 2000; 36: 449-52.

  4. Fridell JA, Saxena R, Chalasani NP, et al. Complete reversal of glycogen hepatopathy with pancreas transplantation: two cases. Transplantation 2007; 83: 84-6.

  5. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine (Baltimore) 1996; 75: 327-33.

  6. Bassett JT, Veerappan GR, Lee DH. Glycogenic hepatopathy: a rare cause of increased aminotransferase levels in a diabetic patient. Clin Gastroenterol Hepatol 2008; 6: A26.

  7. Mauriac P. Gros ventre, hepatomegalie, troubles de las croissance chez les enfants diabetiques traits depuis plusieurs annes par l’insuline. Gazette Hebdomadaire des Sciences Médicales de Bordeaux 1930; 26: 402-10.

  8. Rogal SS, Ukomadu C, Levy BD, et al. Clinical problem-solving. A sweet source of abdominal pain. N Engl J Med 2011; 364: 1762-7.

  9. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.

  10. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.

  11. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007; 46: 1650-8.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2012;11